Back to Archived Journals » Oncolytic Virotherapy » Volume 7
Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Oncolytic Virotherapy
ISSN: 2253-1572
- View all (70)
- Volume 10, 2021 (1)
- Volume 9, 2020 (2)
- Volume 8, 2019 (6)
- Volume 7, 2018 (11)
- Volume 6, 2017 (6)
- Volume 5, 2016 (10)
- Volume 4, 2015 (20)
- Volume 3, 2014 (8)
- Volume 2, 2013 (5)
- Volume 1, 2012 (1)
Archive: Volume 7, 2018
Development and applications of oncolytic Maraba virus vaccines
Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD
Oncolytic Virotherapy 2018, 7:117-128
Published Date: 26 November 2018
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Burton C, Das A, McDonald D, Vandergrift III WA, Patel SJ, Cachia D, Bartee E
Oncolytic Virotherapy 2018, 7:107-116
Published Date: 19 November 2018
Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells
Zhand S, Hosseini SM, Tabarraei A, Saeidi M, Saghaeian Jazi M, Kalani MR, Moradi A
Oncolytic Virotherapy 2018, 7:95-105
Published Date: 30 October 2018
Three-dimensional tumor cell cultures employed in virotherapy research
Kloker LD, Yurttas C, Lauer UM
Oncolytic Virotherapy 2018, 7:79-93
Published Date: 5 September 2018
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Chen CY, Hutzen B, Wedekind MF, Cripe TP
Oncolytic Virotherapy 2018, 7:65-77
Published Date: 31 July 2018
Current understanding of reovirus oncolysis mechanisms
Phillips MB, Stuart JD, Rodríguez Stewart RM, Berry JTL, Mainou BA, Boehme KW
Oncolytic Virotherapy 2018, 7:53-63
Published Date: 14 June 2018
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA
Oncolytic Virotherapy 2018, 7:43-51
Published Date: 3 May 2018
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
Xu C, Goß AV, Dorneburg C, Debatin KM, Wei J, Beltinger C
Oncolytic Virotherapy 2018, 7:37-41
Published Date: 30 April 2018
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Pelin A, Wang J, Bell J, Le Boeuf F
Oncolytic Virotherapy 2018, 7:25-35
Published Date: 28 March 2018
Oncolytic virotherapy in upper gastrointestinal tract cancers
Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ
Oncolytic Virotherapy 2018, 7:13-24
Published Date: 23 March 2018
Potential of oncolytic viruses in the treatment of multiple myeloma
Bartee E
Oncolytic Virotherapy 2018, 7:1-12
Published Date: 23 February 2018